TAK logo

TAK R&D Expenses

Latest reported¥706.18B JPY
TAK TTM R&D Expenses · JPY (¥209.28B → ¥706.18B)
High-resolution chart · PNG

TAK r&d expenses history

Trailing twelve months (TTM) · JPY. Each value covers four complete reported quarters.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) R&D Expenses — Trailing twelve months (TTM) (JPY)
Period endingR&D Expenses (JPY)
706,179,628,000
682,675,628,000
699,767,386,000
691,566,000,000
705,648,000,000
730,220,000,000
710,076,000,000
727,264,000,000
735,646,000,000
729,924,000,000
695,012,000,000
682,260,000,000
652,459,000,000
633,325,000,000
616,009,000,000
569,758,000,000
547,213,000,000
526,086,000,000
495,747,000,000
484,935,000,000
471,492,000,000
455,833,000,000
481,853,000,000
486,996,000,000
482,336,000,000
492,381,000,000
492,477,000,000
447,229,000,000
413,198,000,000
368,298,000,000
317,675,000,000
321,778,000,000
321,720,000,000
325,442,000,000
325,164,000,000
315,433,000,000
311,441,000,000
312,303,000,000
315,828,000,000
336,520,000,000
341,486,000,000
345,927,000,000
386,767,000,000
386,950,000,000
387,931,000,000
382,095,000,000
352,592,000,000
342,989,000,000
338,267,000,000
340,658,000,000
330,010,000,000
323,802,000,000
322,960,000,000
324,292,000,000
231,574,000,000
225,414,000,000
210,901,000,000
189,738,000,000
189,738,000,000
184,807,000,000
185,603,000,000
190,001,000,000
190,001,000,000
197,893,000,000
206,525,000,000
209,279,000,000
209,279,000,000
192,112,000,000
207,635,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.